226 related articles for article (PubMed ID: 37731151)
21. Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation.
Verma V; Rwigema JM; Malyapa RS; Regine WF; Simone CB
Radiother Oncol; 2017 Oct; 125(1):21-30. PubMed ID: 28941560
[TBL] [Abstract][Full Text] [Related]
22. [Reirradiation for head and neck squamous cell carcinoma: Indications and results].
Biau J; Moreau J; Blanchard P; Thariat J; Miroir J; Lapeyre M
Cancer Radiother; 2019 Oct; 23(6-7):559-564. PubMed ID: 31451359
[TBL] [Abstract][Full Text] [Related]
23. A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors.
Gamez ME; Patel SH; McGee LA; Sio TT; McDonald M; Phan J; Ma DJ; Foote RL; Rwigema JM
Int J Part Ther; 2021; 8(1):131-154. PubMed ID: 34285942
[TBL] [Abstract][Full Text] [Related]
24. Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative.
Ward MC; Riaz N; Caudell JJ; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Vargo JA; Heron DE; Higgins KA; Beitler JJ; Marcrom S; Boggs DH; Hassanzadeh C; Reddy CA; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA;
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):586-594. PubMed ID: 28865925
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic factors for head and neck cancer reirradiation: A systematic review].
Ohnleiter T; Truntzer P; Antoni D; Guihard S; Elgard AM; Noël G
Cancer Radiother; 2017 Jun; 21(4):316-338. PubMed ID: 28566248
[TBL] [Abstract][Full Text] [Related]
26. Is It Worth It? Consequences of Definitive Head and Neck Reirradiation.
Foster CC; Fan M; Lee NY; Yom SS; Heaton CM; Deraniyagala R; Amdur R; Weichselbaum RR; Haraf DJ
Semin Radiat Oncol; 2020 Jul; 30(3):212-217. PubMed ID: 32503785
[TBL] [Abstract][Full Text] [Related]
27. Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrences.
Margalit DN; Rawal B; Catalano PJ; Haddad RI; Goguen LA; Annino DJ; Limaye SA; Lorch JH; Lavigne AW; Schoenfeld JD; Sher DJ; Tishler RB
Oral Oncol; 2016 Oct; 61():19-26. PubMed ID: 27688100
[TBL] [Abstract][Full Text] [Related]
28. Patient-oriented toxicity endpoints after head and neck reirradiation with intensity modulated radiation therapy.
Margalit DN; Schoenfeld JD; Rawal B; Haddad RI; Catalano PJ; Goguen LA; Chau NG; Rabinowits G; Lorch JH; Annino DJ; Tishler RB
Oral Oncol; 2017 Oct; 73():160-165. PubMed ID: 28939070
[TBL] [Abstract][Full Text] [Related]
29. The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach.
Cacicedo J; Navarro A; Alongi F; Gómez de Iturriaga A; Del Hoyo O; Boveda E; Casquero F; Perez JF; Bilbao P
Cancer Treat Rev; 2014 Feb; 40(1):178-89. PubMed ID: 23993769
[TBL] [Abstract][Full Text] [Related]
30. What is the role of postoperative re-irradiation in recurrent and second primary squamous cell cancer of head and neck? A literature review according to PICO criteria.
Merlotti A; Mazzola R; Alterio D; Alongi F; Bacigalupo A; Bonomo P; Maddalo M; Russi EG; Orlandi E
Crit Rev Oncol Hematol; 2017 Mar; 111():20-30. PubMed ID: 28259292
[TBL] [Abstract][Full Text] [Related]
31. A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck.
Ward MC; Lee NY; Caudell JJ; Zajichek A; Awan MJ; Koyfman SA; Dunlap NE; Zakem SJ; Hassanzadeh C; Marcrom S; Boggs DH; Isrow D; Vargo JA; Heron DE; Siddiqui F; Bonner JA; Beitler JJ; Yao M; Trotti AM; Riaz N;
Oral Oncol; 2019 Mar; 90():80-86. PubMed ID: 30846182
[TBL] [Abstract][Full Text] [Related]
32. Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors.
Buglione M; Maddalo M; Mazzeo E; Bonomo P; Spiazzi L; Bruni A; Paiar F; Triggiani L; Greto D; Rubino L; Livi L; Bertoni F; Magrini SM
Tumori; 2015; 101(5):585-92. PubMed ID: 26108237
[TBL] [Abstract][Full Text] [Related]
33. Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Mehanna H; Kong A; Ahmed SK
J Laryngol Otol; 2016 May; 130(S2):S181-S190. PubMed ID: 27841130
[TBL] [Abstract][Full Text] [Related]
34. Reirradiation of Recurrent and Second Primary Cancers of the Head and Neck: a Review of the Contemporary Evidence.
Kreinbrink PJ; Lewis LM; Redmond KP; Takiar V
Curr Treat Options Oncol; 2022 Mar; 23(3):295-310. PubMed ID: 35226310
[TBL] [Abstract][Full Text] [Related]
35. Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation.
Choi JI; Khan AJ; Powell SN; McCormick B; Lozano AJ; Del Rosario G; Mamary J; Liu H; Fox P; Gillespie E; Braunstein LZ; Mah D; Cahlon O
Radiother Oncol; 2021 Dec; 165():142-151. PubMed ID: 34688807
[TBL] [Abstract][Full Text] [Related]
36. Impact of Flap Reconstruction on Radiotoxicity After Salvage Surgery and Reirradiation for Recurrent Head and Neck Cancer.
Ho AS; Zumsteg ZS; Meyer A; Riaz N; Rahmati R; Kraus DH; McCarthy C; Wong RJ; Shah JP; Lee NY
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):850-857. PubMed ID: 27506662
[TBL] [Abstract][Full Text] [Related]
37. Second infield re-irradiation with a resulting cumulative equivalent dose (EQD2
von der Grün J; Köhn J; Loutfi-Krauss B; Blanck O; Rödel C; Balermpas P
Head Neck; 2019 Apr; 41(4):E48-E54. PubMed ID: 30521102
[TBL] [Abstract][Full Text] [Related]
38. Head and neck cancer reirradiation with interstitial high-dose-rate brachytherapy.
Hegde JV; Demanes DJ; Veruttipong D; Chin RK; Park SJ; Kamrava M
Head Neck; 2018 Jul; 40(7):1524-1533. PubMed ID: 29573121
[TBL] [Abstract][Full Text] [Related]
39. Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study.
Heron DE; Rwigema JC; Gibson MK; Burton SA; Quinn AE; Ferris RL
Am J Clin Oncol; 2011 Apr; 34(2):165-72. PubMed ID: 20686406
[TBL] [Abstract][Full Text] [Related]
40. Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists.
Furlan C; Arcangeli S; Avanzo M; Mirri MA; Munoz F; Giudici S; Perrone A; Amelio D; Tomio L; Draghini L; Deli AM; Pavanato G; Giuliano FM; Pontoriero A; Ciammella P; Navarria P; Iannalfi A; Buglione M; Guida C; Cammelli S; Iorio V; Cardinali M; Genovesi D; Barsacchi L; Balducci M; Bagnoli R; Berti F; Montesi G; Pasqualetti F; Bonome P; Santoni R; Doino D; Schirru P; Pinzi V; Borzillo V; Ferrarese F; Ferro M; Cicco L; Krengli M; Scoccianti S; Donato V
Tumori; 2018 Dec; 104(6):466-470. PubMed ID: 28315510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
